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Abstract 
Background:  As life expectancy of people with intellectual disabilities (ID) extends into older 
age, dementia is an increasing cause of morbidity and mortality.  Specific Aim: To update 
and summarize current knowledge on dementia in older adults with ID by conducting a 
comprehensive review of the published literature from 1997-2008 with a specific focus on:  1. 
epidemiology of dementia in ID in general as well as in specific genetic syndromes  2.  
presentation and 3. diagnosistic criteria for dementia.  Method: Combination of searches in 
electronic databases Medline, EMBASE, Psych Info for original research papers in English, 
Dutch or German.  
Findings:  Varied methodologies and inherent challenges in diagnosis yield a wide range of 
reported prevalence rates of dementia. Rates of dementia in the population with intellectual 
disability not due to Down syndrome (DS) are comparable to or higher than the general 
population. Alzheimer’s disease in DS is early in onset and the prevalence increases from 
under 10% in the 40s to more than 30% in the 50s, with varying prevalence reported for those 
60 and older.  Incidence rates increase with age. Few studies of dementia in other genetic 
syndromes were identified. Presentation differs in the ID population compared to the general 
population; those with DS present with prominent behavioral changes believed to be due to 
frontal lobe deficits. Discussion:  Dementia is an important disorder of older age in people 
with intellectual disabilities in general as well as people with DS specifically. The challenge for 
the next ten years is to conduct large-scale collaborative studies of high quality to further our 
knowledge on the epidemiology and clinical presentation of dementia in this population.  
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Introduction  
Life expectancy of individuals with intellectual disabilities (ID) has significantly increased 
over the past fifty years and this trend will continue into the future. With increased life expectancy 
comes age-related illness, including dementia. Dementia is a growing source of morbidity and 
mortality in this population. A previous review has suggested that the epidemiological pattern i.e. 
the incidence and prevalence of dementia (particularly Alzheimer’s Disease) among the ID 
population may differ from that in the general population, at least in specific subgroups such as 
Down Syndrome (DS) (Zigman, Schupf, Haveman, & Silverman, 1997). There are also several 
reasons why dementia may present atypically in the ID population. The perception of decline and 
the way it manifests will depend on the premorbid level of ID and pattern of cognitive abilities, and 
the environmental demands placed on the person. Co-morbid conditions such as epilepsy will 
further complicate the picture, and aging itself may contribute to some degree of decline. The 
application of standard diagnostic criteria, which are based on the development of specific 
cognitive deficits in adults without ID, therefore requires careful consideration (Aylward, Burt, 
Thorpe, & Lai, 1997; Janicki, Heller, Seltzer, & Hogg, 1996; Thorpe, Davidson, & Janicki, 2001). 
The study of ‘dementia’ in relation to people with ID is fraught with other anomalies. We 
now know that almost all adults with Down Syndrome have the microscopic plaques and tangles 
associated with a diagnosis of Alzheimer’s Disease (AD) in their thirties, but many never develop 
the signs or symptoms of dementia, and that older males with fragile X pre-mutation may develop 
Fragile X Ataxia Syndrome, characterized by cognitive decline and mobility problems.  
In the lead up to the 13th World Congress of IASSID, the Special Interest Research 
Group on Ageing in Intellectual Disability sought to review the state of recent literature on aspects 
of ageing. This paper reports on the epidemiology and presentation of dementia in people with ID 
– there is an accompanying paper on dementia care-giving issues, and others focus on physical 
health and ageing.  
Aims of this review 
We aimed to update and summarize current knowledge on dementia in older adults with 
ID through a comprehensive review of the published literature over the past decade, i.e. from 
1997 – 2008, addressing: 
1. epidemiology, with a specific focus on genetic syndromes and their 
association with dementia; 
2. presentation and symptoms; and   
3. diagnostic criteria for dementia in this population 
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Method 
Literature search 
We undertook computerized searches of Medline, EMBASE, and Psychinfo using the 
exploded MESH term “mental retardation”, as well as title and abstract searches for equivalent 
terms (mental retardation or mental handicap or intellectual disabilit* or learning disabilit*). We 
also used the MESH term “Down syndrome”, as well as title and abstract searches for equivalent 
terms (Down's syndrome or Down syndrome). These were combined (using the AND function) 
with the exploded MESH term “dementia” as well as title and abstract searches for dementia and 
equivalent terms (Alzheimer's disease or vascular dementia or Parkinson's dementia or Lewy 
body dementia or fronto-temporal dementia or front* degeneration). The search was limited to 
publication dates from 1997, and was undertaken at the end of April 2008. This strategy delivered 
several thousand abstracts.  
Enhanced search for ID syndromes and dementia 
Since the general search term “mental retardation” and its equivalents may not include all 
ID syndromes, and because we had a particular interest in dementia in specific syndromes, 
additional searches were performed for known ID syndromes, which were combined with the term 
“dementia” in the title or abstract.  Finally, we searched for data on mortality in specific syndromes 
(without date limiters), in order to find out whether individuals with a specific syndrome may reach 
adulthood and therefore be at risk of developing dementia.  
Selection of papers 
For this review, we selected all papers in English, Dutch or German reporting original 
research on epidemiology and presentation of dementia in  ID. We also included reviews 
published since 2003. We excluded case reports (unless it described specific syndromes) as well 
as basic sciences research unless it concerned humans with dementia and reported clinical 
associations. The reviewers added relevant publications from their personal collections if not 
already included. All the research papers included in this review are summarized in tables 1, 2 
and 3, but where relevant, other papers were quoted in the text.  
Epidemiology of dementia in adults with ID  
Studies concerned with the prevalence or incidence of dementia in older adults with ID 
are summarized in tables 1 and 2. We have not included studies that have focused on 
longitudinal change without making a diagnosis of dementia, e.g. (Carr, 2003; Oliver, Crayton, 
Holland, Hall, & Bradbury, 1998; Zigman, Schupf, Urv, Zigman, & Silverman, 2002) which are 
summarized elsewhere (Carr, 2005). Since prior research indicates that the risk of dementia, and 
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in particular AD, is much higher among the population with DS, we classified the papers into one 
of the following three categories:  
1) studies which did not distinguish between those with and without DS 
2) studies which focused on the population with DS; 
3) studies which focused on the ID population who do not have Down 
syndrome (non-DS ID).  
The reviewed studies varied considerably in the population studied, in the design of the 
study, and in the size of the population studied. Some included only institutionalized participants, 
but the majority were population-based studies, which involved individuals living in community 
settings as well as in institutions (see tables 1 & 2). Studies that included only institutionalized 
samples may have been biased as people living in long-term facilities are usually more severely 
disabled. The ascertainment of cases differed between studies. Studies that made direct 
assessment of participants and included information given by caregivers as well as medical 
records are likely to have the most reliable estimates of prevalence and incidence. Studies that 
relied on third party report of diagnoses or symptoms rather than on assessments with individual 
participants may have under-estimated dementia rates. In most of the studies we identified, well-
accepted criteria for the diagnosis of dementia in adult population with ID were used, though 
those criteria differed between studies. Different criteria may result in diagnosing different cases. 
A few prevalence studies were able to confirm diagnoses with follow-up assessments, e.g. 
(Zigman, et al., 2004), but most were entirely cross-sectional. Given the methodological 
differences among the studies conducted, it is difficult to undertake direct comparisons of 
findings.  
 With regard to prevalence and incidence studies of dementia in adults with ID, we 
included all studies we found, but used three basic criteria to identify studies which were of 
sufficient epidemiological standard. Firstly, we rated whether samples were representative of the 
ID or DS population. A study was deemed to be representative if it made use of unbiased 
sampling methods, and if it was based on a population that is representative of all older adults 
with ID or DS. However, for practical reasons the vast majority of epidemiological surveys in the 
ID population make use of populations identified by services. We rated studies to be sufficiently 
representative if they included both community and institutional service defined populations.    
Secondly, studies had to have undertaken standardised individual assessments with participants 
to identify potential dementia cases, and thirdly, should have used standardised diagnostic 
criteria to diagnose cases. The studies rated to meet these requirements are marked in tables 1 
and 2, and the main findings of this section were based on these studies.  We acknowledged the 
methodological differences when comparing the estimated rates of dementia across different 
studies.  
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 We did not rate the studies of dementia in rare syndromes according to the above 
criteria, as these populations are very small and there were very few relevant studies . These 
studies are summarised in table (3).  
The majority of studies were conducted in Europe (the Netherlands, Ireland and the UK) 
and the US. There was only one published study from Asia, and none from South America, 
Eastern Europe, Africa or Australia and New Zeeland. The variation in the size of the study 
samples as well as the sample selection methods may explain some of the diversity observed in 
the findings. 
Dementia Prevalence   
Dementia prevalence among population with ID  
A few studies have reported estimates of population-based prevalence of dementia in an 
overall population of persons with ID. Janicki and Dalton (2000) conducted the most recent study 
in New York State, USA, based on a postal survey of known dementia cases amongst adults 
using ID services – individual assessments were not undertaken. The overall prevalence rate of 
6.1% in those aged 60 and older was comparable to that in the general population (Ferri et al, 
2005). Among adults with Down syndrome, the rates were higher - 22% for those aged 40+ and 
56% for those aged 60 and older. The mean age of dementia onset among individuals with Down 
syndrome was 52.8 years. For individuals with other types of ID it was 67.2 years (Janicki & 
Dalton, 2000).  
Dementia prevalence among the population with Down syndrome  
The majority of the prevalence studies we found focused on adults with DS (Table 1).  
Several of these studies were representative surveys, which included adults from community as 
well as institutional settings. Often, the sampling frame was the entire DS population of an area or 
district (Coppus, et al., 2006; Holland, Hon, Huppert, Stevens, & Watson, 1998). These studies 
confirmed that dementia is common in older adults with DS, and that the prevalence increases 
sharply from the age of 40 until the age 60. For example, in the UK, using CAMDEX criteria for 
Alzheimer’s disease prevalence rates increased from 3.4% to 10.3% to 40% among 30-39, 40-49 
and 50-59 age groups, respectively (Holland, et al., 1998). In Ireland, using modified DSM IV 
criteria to diagnose cases, age-specific prevalence rates were as follows: 1.4% for those under 
age 40; 5.7% for those 40-49 years of age; 30.4% for those 50-59 years of age (Tyrrell, et al., 
2001). The largest study of dementia in the DS population to date was in the Netherlands, based 
on the total population of one province and included 506 participants with DS aged 45 years and 
older (Coppus, et al., 2006). Up to the age of 60, the prevalence of dementia doubled with each 
5-year interval. Up to the age of 49, the prevalence was 9%; between the ages of 50 and 54, 
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17.7%; between 55 and 59, it was estimated at 32.1%.    
There was considerable variation between studies for the prevalence of dementia beyond 
the age of 60. Tyrrell and associates (2001) described a rate of 41.7% among those aged 60 and 
over, and 50% among those aged 70 or older; while Coppus et al. (2006) described a decrease in 
prevalence to 25.6% beyond age 60 which was thought to be due to either a decline in incidence, 
or an increase in mortality rate in those with dementia (Coppus, et al., 2006; Tyrrell, et al., 2001). 
One other study, based on an institutional sample, described a rate of 100% in adults with DS 
aged 65 and older (Visser, Aldenkamp, Van Huffelen, & Kuilman, 1997).  
No gender differences have been found for dementia rates in older adults with DS 
(Coppus, et al., 2006; Tyrrell, et al., 2001), but the average age of menopause of women with DS 
was younger than in the general population, and the age at onset of dementia was correlated with 
the age of menopause for those who developed dementia (Cosgrave, Tyrrell, McCarron, Gill, & 
Lawlor, 1999).    
Dementia prevalence among population with non-DS ID  
 Only a few studies focused on the prevalence and/or incidence among adults with ID 
who do not have Down syndrome.  Two studies have been undertaken in the UK (table 1). 
Cooper (1997) conducted a population-based study of 134 elderly people with ID over the age of 
65 (five of whom had DS). Dementia was diagnosed in 21.6% which was substantially higher than 
that found in the general population (Cooper, 1997). Strydom and associates (2007) established a 
sample of 222 urban adults with ID aged 60 and older. Dementia cases were identified after a 
two-phased process – a screening phase, followed by comprehensive assessment of screen 
positives. Using ICD-10, DSM-IV, DC-LD and dementia subtype criteria, the overall dementia 
prevalence was 13.1% (95% CI 8.9-18.2) among those aged 60 and older, and 18.3% (95% CI 
12.3-25.7) among those aged 65 and older. Alzheimer’s disease was the most common type, and 
had a prevalence rate of 12% (7.1 – 18.5%) among those aged 65 and older, three times greater 
than general population rates. Lewy body and fronto-temporal dementias were, interestingly, 
more common than vascular dementia. 
Zigman et al. (2004) conducted a longitudinal study of 126 adults with ID without DS over 
the age of 65 in the USA. The sample consisted of a random selection of registered users of ID 
services, supplemented with a convenience sample and the authors employed comprehensive 
assessments repeated at 18 month intervals.  They identified 10 cases with possible, definite or 
complicated AD (prevalence rate 9% for those aged 65 and older; 12% for those 75 years and 
older). These rates were within the range of rates for older adults without ID in the USA (Zigman, 
et al., 2004).  
The difference in prevalence rates between the UK and US may be explained by the 
methodology. Although the UK estimates were based on samples representative of service users, 
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the diagnoses were based on a single evaluation rather than on longitudinal assessments, and 
this may have over-estimated dementia. The American study may have under-estimated 
dementia by not including all dementia subtypes, by using more restrictive criteria, or by being 
less representative than the UK studies by including a convenience sample. However, like-for-like 
estimates for AD prevalence according to ICD 10 criteria were similar in the UK and USA 
(Strydom, Livingston, King, & Hassiotis, 2007; Zigman, et al., 2004).   
Dementia Incidence    
In dementia incidence studies, it is important to consider the age distribution of the 
cohort, the rigor with which dementia cases at entry are excluded, the length of follow-up and the 
diagnostic methods and criteria used. We have summarised all the incidence studies found in the 
literature search in table 2..     
Dementia Incidence among the population with Down syndrome 
The majority of reviewed studies were of cohorts of individuals with DS, summarised in 
table (2). For example, Visser et al. (1997) described the dementia incidence over a 6 year period 
among 307 institutionalized participants in the Netherlands. Among those aged 40 years and 
above at entry, the incidence rate was 36%. Incidence increased steadily with increasing age, 
and did not appear to taper off in those aged 60 and older (Coppus, et al., 2006). Decreased 
prevalence in adults with DS aged 60 and older noted in this study therefore appeared to be due 
to an increase in mortality of those with dementia, which was more than twice that of those 
without dementia.  
The survival period from onset of dementia at age 55 until death was 3.5 years (SD 2.2) 
for incident cases in an institutional sample of more severely disabled adults (Margallo-Lana, et 
al., 2007), while the mean age at death was 59.3 (SD 10.2) years. In this study, the incidence rate 
of dementia was 25% over 15 years, which seems to be low compared to other studies, possibly 
due to the difficulties in diagnosing dementia in those with profound ID. However, the study was 
unusual in that neuropathological findings were available for many of those who had died and 
among those with a diagnosis of dementia, it was associated with the density of tangles, but not 
plaques.  
Dementia incidence among population with non-DS ID  
Zigman and colleagues (2004) also reported incidence rates from their longitudinal study 
of adults with ID without Down syndrome over the age of 65, although the sample size was 
reduced in each subsequent wave of data collection. The incidence rate for AD  was 8 cases in a 
cohort of an estimated 100 participants (aged 65 – 84) over 3 years, with a cumulative incidence 
rate of 0.31 (Zigman, et al., 2004).   
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Dementia in specific ID syndromes other than DS  
Although we have found several studies describing Fragile X-associated Tremor/Ataxia 
Syndrome (FXTAS), a disorder characterized by progressive action tremor, ataxia and dementia 
that occurs in premutation carriers of the FMR1 (fragile X mental retardation 1) gene (Hagerman 
& Hagerman, 2004), we did not include it in this review because  FXTAS itself is not associated 
with ID. Little attention has been paid to the risk of dementia in other specific ID syndromes. We 
have summarized in table 3 the common syndromes which have been associated with 
development to adulthood. Although these adults often have reduced life expectancy, many reach 
middle age and could therefore develop dementia.  
Several syndromes have “dementia” as a common characteristic – these include 
Cockayne syndrome, Rett syndrome and Sanfilippo syndrome. Cockayne syndrome (Progeria-
Like-Syndrome), a rare autosomal recessive disorder, is characterized by premature ageing, 
including dementia (Rapin, et al., 2006).  
Rett syndrome 
Rett syndrome is a childhood neurodevelopmental disorder which manifests particular 
symptoms at certain ages. The general Rett profile is that of a slow deterioration of gross motor 
performance over the years in contrast with a relatively preserved cognitive ability to 
communicate, mainly with the eyes. The condition stabilizes to some extent after childhood, but 
many of the women with this disorder now live into old age with progressive neuromuscular 
problems (Hagberg, 2005; Halbach, et al., 2008). Occurring almost exclusively in girls, it is 
believed to be due to a mutation in the MECP2 gene on chromosome X, a transcriptional 
repressor presumed to be essential for neuronal function of the maturing brain (Van den Veyver & 
Zoghbi, 2002). Rett syndrome was initially described as being a progressive syndrome of autism, 
dementia, ataxia and loss of purposeful hand use in girls (Hagberg, Aicardi, Dias, & Ramos, 
1983). There is now doubt about the progressive nature of the disorder and whether the term 
“dementia” should be used to describe the deterioration. Because of various functional, physical, 
anatomic and chemical features, it has been hypothesized that Rett syndrome could be a 
disorder of development (Einspieler, Kerr, & Prechtl, 2005). 
Sanfilippo syndrome 
The Sanfilippo syndrome, or mucopolysaccharidosis III (MPS III), is a lysosomal storage 
disease due to impaired degradation of heparan sulfate and includes 4 types, each due to the 
deficiency of a different enzyme: heparan N-sulfatase (type A); alpha-N-acetylglucosaminidase 
(type B); acetyl CoA:alpha-glucosaminide acetyltransferase (type C); and N-acetylglucosamine 6-
sulfatase (type D) (Yogalingam & Hopwood, 2001). The Sanfilippo syndrome is characterized by 
severe central nervous system degeneration, but only mild somatic disease. The onset of clinical 
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features usually occurs between 2 and 6 years; severe neurological degeneration occurs in most 
people between 6 and 10 years of age, and death occurs typically during the second or third 
decade of life. Type A has been reported to be the most severe, with earlier onset and rapid 
progression of symptoms and shorter survival; in type B, people survive into mid-life. A Dutch 
study showed that 18/20 of adults (aged 20-76 years) with Sanfilippo syndrome had dementia 
(Moog, et al., 2007). Another study, which included some of the same individuals as the previous 
study, showed that 17/29 of individuals (aged 7-72 years) had dementia (Skandar, Schoonbrood-
Lenssen, Van den Akker, & Maaskant, 2005).  
Other syndromes  
Although we did not find any papers describing dementia cases in Williams syndrome 
(associated with a microdeletion of the long arm of chromosome 7), a group of researchers 
followed a number of adults with detailed psychometric assessments, and found the syndrome to 
be associated with precocious aging and loss of some cognitive abilities, specifically explicit 
memory functions (Krinsky-McHale, Kittler, Brown, Jenkins, & Devenny, 2005). However, none 
were diagnosed with dementia. Lastly, a study on Prader-Willi syndrome (in most cases due to a  
deletion on chromosome 15) found no dementia cases in a cohort of 74 individuals aged 18-63 
years (Sinnema, Maaskant, Van Schrojenstein Lantman-de Valk, Schrander-Stumpel, & Curfs, 
2008).  
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Table (1): Age-related Prevalence of Dementia in Intellectual Disability (ID) (DS and non-DS)   
     
Authors 
(year) 
Study 
Design 
Location Residence Sample Dementia Criteria Age Overall 
Prevalence 
(%) 
Age-specific 
Prevalence (%) 
Overall ID population 
 
Janicki & 
Dalton, 2000 
 
 
 
 
 
Cross-
sectional 
 
 
 
 
 
 
New York 
State, US 
 
 
 
 
 
 
 
Institution 
and  
Community 
 
 
 
 
 
Overall ID 
Dementia 
cases = 794 
 
DS dementia 
cases = 268 
 
 
Postal survey of all ID 
services in one US 
state; not individually 
assessed; did not use 
specific diagnostic 
criteria 
40+ 
60+ 
80+ 
 
40+ 
60+ 
 
 
 
 
 
 
 
 
 
3.0 
6.1 
12.1 
 
22.1 
56.4 
 
 
Van 
Schrojenstein 
Lantman De 
Valk, et al., 
1997 
Longitudinal The 
Netherlands 
Institution 
and 
community  
overall ID 
n = 1020 
 
 
 
 
 
 
 
 
 
DS 
n = 243 
 
 
 
 
 
 
 
Non-DS ID =  
Questionnaires to 
General Practitioners of 
one Dutch province; not 
individually assessed; 
criteria used not stated 
All ages 
 
 
0-19 
20-29 
30-39 
40-49 
50-59 
60-69 
>70 
 
 
0-19 
20-29 
30-39 
40-49 
50-59 
60 
 
 
All ages 
3.8 
 
 
 
 
 
 
 
 
 
 
16.9 
 
 
 
 
 
 
 
 
2.0 
 
 
 
1.0 
- 
0.8 
5.1 
5.4 
6.2 
17.6 
 
 
- 
- 
- 
22.2 
45.7 
72.7 
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849 0-19 
20-29 
30-39 
40-49 
50-59 
60 
 
 1.3 
- 
1.1 
- 
1.7 
5.9 
Age-related Prevalence of Dementia in Down’s Syndrome (DS) 
 
Coppus, et al., 
2006 
Longitudinal 
study 
The 
Netherlands 
Community 
and 
Institution 
 
506 All providers in 4 
regions; Possible 
cases identified by 
informants, then 
individually assessed; 
diagnosed by ICD-10 
45+ 
45-49 
50-54 
55-59 
60+ 
 
16.8 (16-23) 
 
 
 
- 
8.9 (95% CI 5-12) 
17.7 (95% CI 12-23) 
32.1 (95% CI 22-42) 
25.6 (95% CI 12-40) 
Tyrrell, et al., 
2001 
 
 
 
 
 
Cross-
sectional 
Ireland Community 
and  
Institution 
285 All DS users of 
selected providers of 
ID care across 
Ireland; individually 
assessed; diagnosed 
by DSM IV 
35+ 
35-40 
40-49 
50-59 
60+ 
70+ 
13.3 
 
 
1.4 
5.7 
30.4 
41.7 
50.0 
Van 
Buggenhout, et 
al., 1999 
Cross-
sectional 
The 
Netherlands 
Residents of 
one large 
Institution  
96 Institutional sample;  
individually assessed; 
criteria not stated 
50+ 42.4  
 
 
 
 
Holland, et al., 
1998 
Cross-
sectional 
UK Community 
and  
Institution 
75 All providers of one 
region; Individually 
assessed; . 
ICD 10; DSM IV,  
CAMDEX-AD, DLB 
and FTD criteria 
 
 
 
 
30+ 
 
 
30-39 
40-49 
50-59 
 
30+ 
 
 
24.0 (All 
dementias) 
 
 
 
 
 
13.3 
(CAMDEX 
AD) 
 
 
 
20.7 
20.7 
40.0 
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30-39 
40-49 
50-59 
 
 3.4 
10.3 
40.0 
 
Sekijima, et al., 
1998 
Longitudinal 
assessment 
(1 year) 
Japan Institution 106 Institutions in one 
prefecture; Individually 
assessed, including  CT 
scans; 
Criteria not specified 
30+ 
30-39 
40-49 
50+ 
 
15.1 
 
 
0.0 
16.0 
41.0 
Visser, et al., 
1997 
Longitudinal The 
Netherlands 
Institution 307 Institutional sample; 
Individually assessed 
including EEGs; criteria 
not specified 
 
All ages 
 
<39 
40-49 
50-59 
60-69 
>70 
 
 
18%  
 
0.0 
11.0 
66.0 
77.0 
100.0 
 
Age-related Prevalence of Dementia in non-DS ID 
 
Cooper, 1997 Cross-
sectional 
UK Community 
and  
Institution 
134 Service user sample 
with no outreach; 
individually assessed;  
ICD-10 criteria 
 
65+ 
65-74 
75-84 
85-94 
21.6 
 
- 
15.6 
23.5 
70.0 
Zigman, et al., 
2004 
Longitudinal New York 
State, USA 
Community 
And  
Institution 
126 Random sample from 
state wide service 
register plus 
convenience sample. 
Individually assessed. 
DSM-IV AD criteria 
 
possible/definite AD 
or “uncertain with 
complications” 
 
 
 
 
 
65+ 
75+ 
 
 
 
 
 
 
 
 
 
9.0 (95% CI 4.2-16.4) 
12.1 (95% CI 5.0-23.3) 
 
 
 
Strydom, et Cross- UK Community 222 All adults receiving    
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al., 2007 sectional (urban) 
And 
institution  
care in 5 London 
boroughs; Potential 
cases identified 
through screen then 
individually assessed  
ICD-10, DSM-IV, or 
DC-LD 
Any dementia 
 
 
AD on any criteria 
VaD on any criteria 
DLB on any criteria 
FTD on any criteria 
 
 
 
 
60+ 
65+ 
 
65+ 
65+ 
65+ 
65+ 
 
 
 
13.1 
18.3 
 
 
 
 
 
 
 
 
 
12.0 (95% CI 7.1-18.5) 
3.5 (95% CI 1.2-8.0) 
7.7 (95% CI 3.9-13.4) 
4.2 (95% CI 1.6-9.0) 
 
 
 
Studies that were rated to be of high epidemiological standard are marked in bold (See text).  
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Table (2): Incidence of dementia in ID  
 
Authors (year) Study 
Design 
Location Residence Sample Dementia Criteria Age Follow
-up 
(Yrs) 
# of 
Incident 
Cases 
Incidence 
Overall ID population 
 
Van 
Schrojenstein 
Lantman-de 
Valk et al. 1997 
Longitudinal The 
Netherlands 
Institution 
and 
community 
homes 
 
1041 ID 
 
 
 
 
 
 
214 DS 
 
 
 
 
827 non-
DS ID, 
 
 
 
 
Questionnaires to 
General Practitioners; 
no assessments 
completed with 
participants; criteria 
used not known 
 
All ages 
 
 
 
 
 
 
30-39 
40-49 
50-59 
60 
 
30-39 
40-49 
50-59 
60 
 
30-39 
40-49 
50-59 
60 
 
3 
 
 
 
 
 
 
 
 % 
2.7 
 
 
 
 
 
 
0.5 
5.6 
2.9 
5.7 
 
0.0 
24.0 
27.6 
80.0 
 
0.6 
0.0 
1.5 
5.1 
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Incidence of dementia in Down’s Syndrome 
 
Margallo-Lana, 
et al., 2007 
 
Longitudinal UK Institution 92 Institutional sample; 
individually assessed;  
ICD10 criteria 
Neuropathology 
 
38 
(Median 
age at 
start) 
15 
years 
18 25% over 15 years 
Coppus et al. 
2006 
Longitudinal 
 
The 
Netherlands 
Institution 
And  
Communit
y 
 
506 All providers of 4 
regions; Possible 
cases identified by 
informants, then 
individually 
assessed; 
diagnosed by ICD-
10 
 
 
<50 
50-54 
55-59 
≥60 
 
Mean 
3.3 
years 
 
18 
14 
8 
9 
Per 100 person years 
2.5 
2.8 
4.9 
13.3 
Holland, Hon, 
Huppert, & 
Stevens, 2000 
Longitudinal UK Communit
y 
And  
Institution 
68 All providers of one 
region; individually 
assessed; 
ICD 10; DSM IV,  
CAMDEX-AD, DLB 
and FTD criteria 
 
 
30+ 
30-39 
40-49 
50-59 
18 
month
s 
 
13 
6 
5 
2 
% 
24.5 
26.1 
26.3 
22.2 
 
Incidence of dementia in non-DS ID 
 
Evenhuis, 
(1997) 
Retrospective 
Follow-up 
study 
The 
Netherlands 
Residents 
of one 
large 
Institution 
144 Institutional sample; 
Individually assessed 
DSM-III-R 
60+ 
 
60-69 
70-79 
≥80 
 
11  
 
1 
5 
3 
 
% 
1.6 (0.0-4.7) 
19.1 (2.4-35.8) 
29.1 (0.0-62.1) 
Zigman et al. 
(2004) 
Longitudinal New York 
State, USA 
Communit
y 
And  
Institution 
100 
(approx) 
See above; 
DSM-IV (AD only) 
possible/ definite 
dementia or 
 
65-84 
 
 
 
3 
 
8 
 
cumulative incidence 
0.31  
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“uncertain with 
complications” 
 
 
 
 
 
Studies that were rated to be of high epidemiological standard are marked in bold (See text).  
 
Dementia in older adults with ID  19 
Table 3.  Specific syndromes: life expectancy, and dementia. 
 
Syndrome Cause Life Expectancy (LE) 
 
Dementia 
Angelman Most: deletion 
chromosome 15 
Reaching adulthood; Reduced LE (<10-15 years) 
(Angelman-Syndrome-Foundation;  Williams, 2008) 
 
N=1 (case-study) 
(Bjerre, Fagher, Ryding, & Rosen, 
1984) 
Regional cerebral blood flow studies 
showed reduced cerebral circulation 
compatible with organic dementia 
 
Coffin Lowry Most: mutation X- 
chromosome 
 
Reaching adulthood, Reduced LE (Hunter, 2002) - 
Cornelia de Lange Most: mutation 
chromosome 5 
Reaching adulthood; Reduced LE (Begeman & Duggan, 
1976; The-Cornelia-de-Lange-Syndrome-Association, 
2008) 
 
- 
Cri du Chat Deletion chromosome 5 Reaching adulthood; Reduced LE (Mainardi, et al., 2006) 
 
- 
Fragile X Mutation X-
chromosome 
Reaching adulthood; Reduced LE (-10 y) (Partington, 
Robinson, Laing, & Turner, 1992) 
 
- 
Kabuki 
 
Unknown Reaching adulthood; Normal LE (?) (Kabuki-Syndrome-
Network, 2008) 
 
- 
Klinefelter Extra X-chromosome Slightly reduced LE (2 y) (Bojesen, Juul, Birkebaek, & 
Gravholt, 2004; Swerdlow, Higgins, Schoemaker, Wright, & 
Jacobs, 2005) 
 
- 
Laurence Moon 
Bardet Biedl 
Most: mutation 
chromosome 11 
 
Reaching adulthood; Reduced LE (Riise, 1996) - 
Prader Willi Most deletion 
chromosome 15 
Reported sudden deaths; Reaching adulthood; Reduced 
LE (?) (Einfeld, et al., 2006) 
 
0/74 (Sinnema, et al., 2008), based on 
parental report of dementia symptoms 
Rett Mutation X- Reported sudden deaths; Reaching adulthood (Guideri & See text 
Dementia in older adults with ID  20 
chromosome Acampa, 2005; Laurvick, et al., 2006) 
 
Rubinstein Taybi Most: mutation 
chromosome 16 
Reaching adulthood; Reduced LE (Mijuskovic, Karadaglic, 
& Stojanov, 2006) 
 
- 
Sanfilippo A: mutation chr 17 
B: mutation chr 17 
C: mutation chr 8 
D: mutation chr 12 
 
Reaching adulthood; Reduced LE (see text) 18/20 (Moog, et al., 2007) based on 
review of medical records 
17/29 (Skandar, et al., 2005) based on 
questionnaires to medical specialists 
 
Sotos Mutation chromosome 5 Expected Normal LE (National Institute of Neurological-
Disorders and Stroke, 2007) 
 
- 
Velocardiofacial 
syndrome 
Deletion chromosome 
22 
 
Reaching adulthood 
 
N=1, case- study (Evers, Vermaak, 
Engelen, & Curfs, 2006) based on 
clinical assessment and DSM-IV criteria 
 
Williams Deletion chromosome 7 Reported sudden deaths but reaching adulthood (Bird, et 
al., 1996; Wessel, et al., 2004) 
 
See text 
Wolf-Hirschhorn Deletion chromosome 4 Reaching adulthood; Reduced LE (Shannon, Maltby, 
Rigby, & Quarrell, 2001) 
 
- 
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Presentation of dementia in adults with ID 
A discussion on the presentation of dementia in ID is complicated by several issues. The 
first is that studies of dementia in this population rarely make a distinction between dementia 
subtypes. Secondly, dementia presentation may differ between people according to the severity 
of pre-existing ID. Lastly, it is important to distinguish the presentation of dementia in subgroups 
such as those with DS, because their unique cognitive profile and biological characteristics may 
be influential (Teipel & Hampel, 2006). We have therefore focused on aspects of dementia 
presentation specific to adults with DS separately from other adults with ID.  
We have included all the studies that met our initial selection criteria, but have not rated 
the studies according to methodological quality because researchers have used a broad range of 
methods. Table 4 lists all the studies we found.   
Dementia symptoms in adults with DS 
Table 4 includes studies that have examined the presentation of dementia by observing 
the development of symptoms over time (longitudinal studies), or by making comparisons 
between those with and without dementia (cross-sectional studies).  
Trigger symptoms in people with DS 
Recent studies have continued the work of earlier authors e.g. Evenhuis, (1990) to 
describe the “trigger” symptoms associated with diagnosis of dementia in DS. Common 
symptoms included memory loss and deterioration in speech, personality and behavioral 
changes, disorientation, and functional deterioration (Cosgrave, Tyrrell, McCarron, Gill, & Lawlor, 
2000; Visser, et al., 1997). Up to half of the cases presented with neurological symptoms, such as 
seizures and incontinence which are usually signs of advanced disease, suggesting that 
dementia presents atypically in DS, or reflecting the diagnostic difficulties, especially in those with 
more severe ID. Deb et al. (2007) made a qualitative summary of caregivers’ reports of early 
symptoms. Forgetfulness and confusion were the most prominent symptoms but many 'frontal 
lobe'-related symptoms that usually manifest later in the course of dementia among the general 
population, were also common. These included slowness in activities and speech, loss of interest 
and withdrawal, and the emergence of emotional and behavior problems (Deb, Hare, & Prior, 
2007).  
Memory and other cognitive changes in people with DS 
Several researchers have used sequential cognitive assessments to track the changes 
that occur with the development of dementia in adults with DS. Similar to AD in the general 
population, memory change appears to be an early symptom in DS and is present before the 
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person meets the full clinical criteria for dementia (Devenny, Krinsky-Mchale, Sersen, & 
Silverman, 2000; Devenny, Zimmerli, Kittler, & Krinsky-Mchale, 2002; Krinsky-Mchale, Devenny, 
& Silverman, 2002). Cognitive decline associated with early and middle stage dementia involved 
progressively more areas of cognitive functioning, starting with complex cognitive functions, 
followed by visual organization as well as verbal memory before affecting semantic and short-
term memory (Devenny, et al., 2000).  
These results are in keeping with other studies that have demonstrated that the diagnosis 
of dementia was associated with early deficits in both memory and executive functioning tasks 
(Ball, Holland, Treppner, Watson, & Huppert, 2008; Kittler, Krinsky-McHale, & Devenny, 2006) 
though it is not clear whether these develop together or sequentially. Dyspraxia occurs at a later 
stage (Crayton, Oliver, Holland, Bradbury, & Hall, 1998; Dalton, Mehta, Fedor, & Patti, 1999).  
Functional, personality or behavioral changes  
Many studies have sought caregiver reports on the presentation of dementia, often out of 
necessity, given the ability profile of many adults with DS. Cosgrave et al. (2000) described 
decline in activities of daily living (ADL) as a trigger symptom in 48% of their dementia cases, 
which progressed from deterioration in personal hygiene to housekeeping skills and spatial 
orientation (Cosgrave, et al., 2000; Prasher, Chung, & Haque, 1998). These continued to 
deteriorate with progression until it floored, with dressing, spatial orientation and eating being the 
last to floor.  
Several studies have confirmed earlier reports of prominent personality and behavioral 
change in those with DS and dementia (Lai & Williams, 1989) and they appear to be a harbinger 
of the disorder in adults with DS (Ball, et al., 2006; Holland, et al., 2000; Nelson, Orme, Osann, & 
Lott, 2001). Ball et al. (2006) made the interesting observation that many older adults with DS 
meet criteria for dementia of frontal type which they described as a preclinical stage of AD, before 
they progress to meeting the criteria for AD. They also showed that personality change is 
associated with executive dysfunction (Ball, et al., 2006; Ball, et al., 2008). Individuals with 
dementia displayed an increased number of and more severe  maladaptive behaviors (Prasher, et 
al., 1998; Urv, Zigman, & Silverman, 2008) that can be divided into two types – behavioural 
excesses such as irritability, aggression or self-abusive behaviour, or behavioural deficits such as 
general slowness, apathy or loss of interest, and decreased social engagement (Cosgrave, et al., 
1999; Deb, Hare, & Prior, 2007; Huxley, Van Schaik, & Witts, 2005; Urv, et al., 2008). Behavioral 
excesses rather than deficits triggered referral for dementia assessment (Adams, et al., 2008). 
This has important implications - many older adults with DS may have dementia symptoms but do 
not get assessed until their behavior becomes troublesome to their caregivers. 
One study compared the behavioral and emotional changes associated with AD between 
30 individuals with DS and AD, and 30 individuals with AD from the general population (Temple & 
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Konstantareas, 2005). The DS group experienced fewer delusions and problem behaviors overall 
but was more physically active compared to the AD-only individuals.  
Neurological and other physical findings 
Epilepsy and myoclonus is often associated with dementia in DS, especially in those with 
severe ID (Cosgrave, et al., 2000; Margallo-Lana, et al., 2007; Tyrrell, et al., 2001; Visser, et al., 
1997).  Late onset myoclonic epilepsy in DS (LOMEDS) is characterized by myoclonic jerks on 
waking, generalized tonic-clonic seizures, and generalized spike and wave on EEG; an 
interesting observation is that AD and progressive myoclonic epilepsy are both linked to 
chromosome 21 (Menendez, 2005). Pathological reflexes such as grasping and sucking reflexes 
and concomitant atrophy on neuro-imaging was shown to be significantly related to behavioral 
changes associated with frontal lobe problems (Nelson, et al., 2001).  This is in keeping with the 
hypothesis that frontal dysfunction is a prominent feature of dementia in DS. Other common 
neurological symptoms have included rigidity and postural abnormalities (Margallo-Lana, et al., 
2007).  
Those with dementia have more health co-morbidities than those without (McCarron, et 
al., 2005) especially lung disease, gastro-intestinal disorders, visual and hearing impairments; 
and often lose weight (Prasher, Metseagharun, & Haque, 2004). This might be due to dysphagia 
or other factors such as loss of appetite, difficulty with feeding, malabsorption, and concomitant 
medical conditions (Lazenby, 2008). Some may require tube feeding as their condition 
deteriorates (McCarron, et al., 2005). 
End-stage symptoms   
Cosgrave et al. (2000) and Visser et al. (1997) have described 14 and 41 subjects 
respectively with end stage dementia. All were unresponsive to their environment and lost the 
ability to speak. They were totally dependent and unable to walk, all were incontinent, and almost 
all had seizures and many had Parkinsonian features.  
Dementia presentation in older adults with non-DS ID 
In a UK study of 26 dementia cases caregivers descriptions at first presentation of 
symptoms included a general deterioration in functioning (50%), followed by behavioral or 
emotional change (15%). Deterioration in memory and other cognitive functions were less 
prominent in the early stages of the disorder (Strydom, et al., 2007). Other signs included signs of 
depression such as lack of energy, low mood, and disturbed sleep; persecutory delusions and 
auditory hallucinations, or delirium; while late stage symptoms such as urinary incontinence, 
difficulty in walking and fecal incontinence were surprisingly common (Cooper & Prasher, 1998; 
Evenhuis, 1997). Compared to those with DS and dementia, aggression occurred with greater 
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frequency in those with non-DS ID, but the DS cases had a higher prevalence of other behavioral 
changes (Cooper & Prasher, 1998). 
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Table 4: Studies of the presentation of dementia in DS since 1997  
 
Authors Number & age of 
participants  
 
Type of study Presentation under study Main findings 
Visser, et al., 1997 
 
N = 307, age 10 – 72; 56 
had dementia 
 
Longitudinal Onset and progression of 
symptoms 
Initial onset was non-specific (loss of 
interest, motivation etc.). See text for 
end stage symptoms 
Prasher, et al., 1998 N = 128, age 16 – 72; 17 
had dementia 
Longitudinal Adaptive behavior Functional decline strongly 
associated with dementia 
Cosgrave, et al., 1999 N = 128, mean age 49; 30 
had dementia 
Cross-sectional Adaptive and maladaptive 
behaviour 
Increased self-abusive behavior and 
decreased social engagement 
predicted by dementia 
Cosgrave, et al., 2000 N = 80, females only,  age 
35 – 71; 35 had dementia 
Longitudinal Adaptive behavior & 
cognitive symptoms 
Identified trigger symptoms and 
symptoms associated with 
progression (see text) 
Devenny, et al., 2000 N = 66, mean age 53; 10 
with cognitive decline and 
12 with dementia 
Longitudinal Sequence of cognitive 
decline 
Memory decline predominant, with 
progressive involvement of other 
cognitive functions 
Nelson, et al., 2001 N = 26, mean age 40 (9 
classified as “probable 
dementia”) 
Longitudinal Neurological abnormalities, 
emotional and cognitive 
symptoms; neuro-imaging 
Brain atrophy on  MRI and abnormal 
frontal reflexes associated with 
emotional and cognitive symptoms 
Puri, Ho, & Singh, 2001 N = 68, age 29 – 83 (?n 
with AD) 
Unknown Epilepsy Late onset but not young onset 
epilepsy associated with dementia 
Tyrrell, et al., 2001 N = 285, age 35-74;  38 
with dementia 
Cross-sectional Clinical characteristics Dementia associated with onset of 
epilepsy (OR  = 9.6) & myoclonus 
Devenny, et al., 2002 N = 94, mean age 55; 19 
with dementia 
Longitudinal Memory; cognitive 
assessment 
Memory decline  present several 
years before dementia diagnosis 
Krinsky-Mchale, et al., 
2002 
N = 85, 14 had dementia Longitudinal Memory and cognition  Verbal explicit memory deficits 
demonstrated in early dementia 
Prasher, et al., 2004 N = 48, age 41-60; 24 with 
dementia 
Longitudinal Body weight; physical 
assessment 
Ageing associated with weight loss; 
more if dementia  
Huxley, et al., 2005 N = 34, mean age 53; 15 
diagnosed with dementia 
Cross-sectional Maladaptive behavior More frequent and severe behavior 
problems in dementia 
Ball, et al., 2006 N = 55, age 37 - 72; 10 had 
dementia 
Longitudinal Personality or behavior & 
cognitive change 
Behavior changes and executive 
dysfunction occur early  
Deb, Hare, & Prior, 24 caregivers of adults with Qualitative study Caregiver report of early See text  
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2007 
 
DS and dementia symptoms of dementia 
Margallo-Lana, et al., 
2007 
N = 92, median age 38 at 
entry; 18 incident cases  
Longitudinal (15 
years) 
Caregiver report and 
cognitive assessment 
Neurological signs are common; 
neuropathological findings 
Ball, et al., 2008 N = 103, aged 36 – 72; 25 
had dementia 
Cross-sectional Executive dysfunction, 
memory and personality 
change 
Informant reported personality 
changes accords with executive 
function deficits  
Urv, et al., 2008 N = 251, age 45 and older; 
38 with dementia 
Longitudinal Maladaptive behavior See text  
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Diagnostic criteria for dementia in adults with ID 
Given the difficulty in demonstrating cognitive deficits in adults with ID and the differences 
in presentation when compared to the general population, it is important to investigate the 
performance of diagnostic criteria for dementia in this population. A previous working group 
recommended the use of ICD10 criteria (Aylward, et al., 1997) as these put more emphasis on 
non-cognitive symptoms such as emotional lability and apathy, which are often prominent signs of 
dementia in adults with ID. ICD10 dementia criteria have been modified for use in adults with ID 
(DC-LD criteria) (Cooper, Melville, & Einfeld, 2003).  
Several studies have systematically investigated dementia diagnostic criteria in older 
adults with ID. Clinical judgment, based on ICD10 criteria, resulted in more adults with DS 
diagnosed with dementia than methods based on test batteries (Burt, et al., 2005a). Memory 
decline was the most commonly met criterion. Similar to the general population the criterion for 
emotional and behavioral change was met less often (Burt, et al., 1998).  Holland et al. (1998) 
found that DSM IV and ICD10 AD criteria diagnosed the same adults with DS with dementia, but 
CAMDEX AD criteria were more inclusive. Strydom et al. (2007) compared ICD10, DSM IV and 
DC-LD criteria in a sample of older adults with non-DS ID. Although correlations between the 
criteria were good, DSM IV criteria diagnosed more participants with dementia than ICD10 
criteria. ICD10 criteria excluded several cases with moderate to severe dementia. Behavioral and 
emotional changes, a requirement for diagnosis according to ICD10, were not good at 
discriminating those with and without dementia, and reduced the number of people diagnosed 
using ICD10 criteria.  
Conclusions 
Over the past ten years there have been many cross-sectional and longitudinal studies 
on the prevalence, incidence and presentation of dementia in adults with ID. This has contributed 
to our knowledge of the disorder in this population. In particular, we have a better understanding 
of the early symptoms and course of dementia, especially in adults with DS. However, there have 
been few comparisons on the presentation of dementia between adults in the general population, 
and adults with DS and non-DS ID. Such comparisons are important for clinical as well as 
theoretical reasons. The presentation and epidemiology of dementia subtypes other than AD also 
require more attention in the future.  
It has been established that in adults with Down syndrome, signs and behaviors 
associated with dementia of Alzheimer’s type (or other subtypes such as fronto-temporal 
dementia) emerge during the 5th and 6th decades in approximately one in three of these adults.  
Age of onset was in the mid 50s, much younger than in the general population. The prevalence 
increases to the age of 60, but appears to fall after this, possibly due to the increased mortality 
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associated with dementia where the mean time to death may be as short as 3 to 4 years after 
diagnosis. Incidence rates show no decline with aging. A significant proportion of older adults with 
DS never develop clinical signs of dementia.  
Some studies have shown an increased prevalence of dementia in adults with ID who do 
not have Down syndrome, while others have demonstrated rates similar to that of the general 
population. This may be explained partially by the fact that some studies included all dementia 
subtypes, while others focused on AD.  The severity of ID in the participants may also be a factor 
since it is difficult to diagnose dementia in adults who are more disabled. The age of onset 
(approximately 67 years) was slightly younger than in the general population.  
Despite progress in our knowledge of the epidemiology of dementia in ID, there are still 
many differences in the findings between studies which appear to be a reflection of how 
representative the samples are, the type of study (cross-sectional or longitudinal), identification of 
possible cases, and the different diagnostic criteria used. The variation in findings and 
methodology was particularly prominent in the results obtained from the small number of studies 
in adults with ID who do not have Down syndrome.  
In the future, larger studies with representative samples using comparable ascertainment 
and diagnostic methods, and a good description of participants, could clarify these findings. 
Agreement between researchers on the use of instruments and criteria will help to reduce 
variation between studies, and enable us to show potentially important temporal, geographical or 
between-group differences in the epidemiology of dementia. Another area for future studies is to 
identify biological and/or environmental factors that increase or decrease the risk of age-related 
functional decline in people with ID. This is an important area of inquiry as it may inform the 
development of preventative treatments and programs. 
It is surprising that aging and cognitive functioning has been studied in so few of the ID 
syndromes other than DS, for example, we did not find any dementia studies in even relatively 
common syndromes such as Fragile X Syndrome. This is a neglected area but potentially very 
interesting, as it might help to highlight variation in biological aging and its impact on cognitive 
functioning due to genetic or other factors. Since these special populations are often very small, it 
will require regional and international collaborations. The challenge for the next decade is to 
undertake high quality, large-scale collaborative studies of aging and cognitive functioning in the 
ID population.   
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